Currently Browsing

Our Products

Fenofibric Acid Delayed-Release Capsules 135 mg – 90/Bottle

Overview

Reference Brand:
Trilipix®
Therapeutic Class:
Cardiovascular

Specifications

GCN:
16105
Strength:
135 mg
Size:
90
NDC #:
59651021790
TE Code:
AB

Order Information

Case Qty (min order qty):
24
Case Weight (lbs):
4.766

Attributes

Physical Form:
Capsules
Shape:
Capsules
Color:
Blue/Yellow
Imprint:
"CFB" / "135"
Prescribing Info
Product News

May 02, 2025 | Aurobindo Receives FDA Approval for Varenicline Tablets, 0.5 mg and 1 mg ... Read more

Product News

April 30, 2025 | Aurobindo Receives FDA Approval for Oxcarbazepine Extended-Release Tablets, 150 mg, 300 mg, and 600 mg ... Read more

Product News

April 25, 2025 | Aurobindo Receives FDA Approval for Chlorpromazine Hydrochloride Tablets USP, 10 mg, 25 mg, 50 mg, 100 mg and 200 mg ... Read more